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So far, patient was afebrile after 4 weeks of voriconazole
therapy. The post operatieve wound was cleaned with no
pus discharged or slough.
PP-068 In vitro antifungal susceptibility of Candida
species isolated from patients with cancer
T. Shokohi1 *, Z. Bandalizadeh1, M. Taghi Hedayati1,
S. Mayahi1. 1Deptartment of Mycology and Parasitology,
Sari Medical School, Mazandaran University of Medical
Sciences, Sari, Iran
Background: The genus Candida are one of the most
frequent opportunistic pathogen in patients treated with
immunosuppressive agents, cytotoxic and radiotherapy.
Cytotoxic drugs have a major effect on the cell-
mediated immunity and patients receiving such therapy are
particularly vulnerable to opportunistic Candida infections.
Epithelial cell of buccal mucosa are very sensitive to cancer
therapies which may predispose the patients to candidiasis.
Invasive candidiasis is frequently associated with primary
buccal infections.
The virulence and antifungal susceptibility often vary among
strains. In this study, we analyzed the in vitro antifungal
susceptibility of 69 Candida species isolated from patients
with cancer.
Method: The clinical strains were isolated from, lip, throat
and tongue of patients with cancer in four university
hospitals, Mazandaran Province. These strains were
previously identiﬁed by phenotypic and molecular methods.
In vitro antifungal susceptibility to amphotericin B,
itraconazole, fuloconazole, caspofungin was determined
using the microdilution method described in the CLSI M27-A3
guideline.
Result: Fluconazole resistance was detected in 2 isolates
(2.9%), among Candida albicans (2.5%) and Candida glabrata
strains (8.3%). Itraconazole resistance was determined in 5
isolates (7.3%), among Candida albicans (5%) and Candida
glabrata strains (20%). Amphotericin B resistance was
detected in 3 isolates (4.3%), among Candida albicans
(2.5%), Candida glabrata (8.3%). and Candida tropicalis
(12.5%) strains. Caspofungin resistance was detected in one
Candida tropicalis strain (12.5%).
Conclusion: In the present study, the antifungal activity of
caspofungin was superior against clinical isolates of Candida
species.
PP-069 Neuraminidase N1 of the 2009 pandemic
swine-origin inﬂuenza A virus H1N1 has a
Group-2 speciﬁc active cavity
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Microbiology, Chinese Academy of Sciences, Beichen West
Road, Beijing 100101, China, 2College of Life Sciences,
University of Science and Technology of China, Hefei
230027, Anhui Province, China, 3Graduate University,
Chinese Academy of Sciences, Beijing 100049, China,
4Beijing Institutes of Life Science, Chinese Academy of
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The 2009 pandemic inﬂuenza seemingly spreads extremely
quickly with worrisome mortalities and resembles some
characteristics of the previous three pandemics (1918
Spanish-ﬂu, 1957 Asian-ﬂu and 1968 Hong Kong-ﬂu). The virus
was recognized as a new swine-origin H1N1 inﬂuenza A virus
(S-OIV). Functional and structural characterization of the
neuraminidase (NA) (09N1) might give us some clues about
its pathogenesis and directs the drug application. Here the
09N1 was prepared in a baculovirus-based system and its
enzymatic activity was veriﬁed in vitro. Its crystal structure
has been solved (1.9 A˚) and the structure surprisingly shows
a Group 2 active cavity, different from other known N1
structures which are all categorized into Group 1. The 09N1
structures in complex with substrate sialic acid, Oseltamivir
(Tamiﬂu®) or Zanamivir (Relanza®) have also been solved at
1.8 A˚, 1.7 A˚ and 1.9 A˚ respectively, showing typical binding
modes and revealing the structural basis of the effectiveness
of the NA-targeted drugs against the 2009 pandemic. This is
the ﬁrst solved NA structure derived from swine and the ﬁrst
complex structure with sialic acid for Group 1 members.
PP-070 Application of extracorporeal membrane
oxygenation in respiratory failure patients with
H1N1 inﬂuence: four cases report
H.F. Xiong1 *, L.-M. Guo1, X.-W. Li1, Y.-Q. Jiao1, B.-S. Li1.
1Beijing Ditan Hospital, China
Objective: To evaluate the outcome of extracorporeal
membrane oxygenation (ECMO) in critical ill patients with
H1N1 inﬂuence.
Methods: From NOV15 to Dec 25, 2009, four conﬁrmed
critical ill cases of pandemic H1N1 Inﬂuence were treated
with ECMO.
Results: After using of ECMO, three patients evacuated
the ECMO devices successfully, two (50%) patients died
and two patients had been discharged from hospital.
After treatment, the oxygenation index improved from
48 77mmHg (mean 59.8) to 122 254mmHg (mean 191.8).
The complications included hemorrhage, catheter infection,
and thrombosis in oxygenation membrane.
Conclusion: ECMO support may be helpful in some inﬂuenza
cases with severe refractory pulmonary failure despite
conventional management.
PP-071 Clinical features of critically ill pregnant
patients with inﬂuenza A (H1N1) infection
H.F. Xiong1 *, L.-M. Guo1, X.-W. Li1, Y.-Q. Jiao1, B.-S. Li1,
P. Xiang1, J. Guo1, M. Zhang1, W.-L. Li1, L. Pu1,
L.-C. Zhang1. 1Beijing Ditan Hospital, China
Objective: To describe the clinical features of critical ill
patients with H1N1 inﬂuence in pregnant women.
Methods: From May 15 to Dec 20, 2009, seventeen cases
of pandemic H1N1 in pregnant women were admitted to
hospital and six were critical ill patients. The clinical
features and supplemental data were analyzed.
Results: They ranged in age from 22 27 years (media 24.7),
the gestational weeks on falling ill was 25 36 years (media
30.5), all were in the third trimester. Two patients died,
other four patients had been discharged from hospital. The
most common symptoms were fever, coughing, shortness
of breath, and hemoptysis. Shortness of breath and
hemoptysis were only found in critically ill patients. Anemia,
hypoproteinemia, elevation of CRP, LDH, HBDH and decrease
of T lymphocyte subpopulations count were easily found in
critically ill patients. All patients developed pneumonia and
subsequent acute respiratory distress syndrome, and four
patients required mechanical ventilation, three patients
required Extracorporeal Membrane Oxygenation (ECMO).
Emergency caesarean delivery was preformed in three
patients for premature rupture of membranes (in two
cases) and dead fetus in uterus (in one case) and one
patient delivered a dead fetus herself in hospital. Other
two patients continue their pregnancy after discharge from
hospital.
Conclusion: Pregnant women might be at increased risk
for critical ill complications from pandemic H1N1 virus
infection, especially in the third trimester. The symptoms
of shortness of breath and hemoptysis may be helpful in
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detection of critically ill patients. Most critical care patients
required mechanical ventilation and had a high case-fatality
rate.
PP-072 Comparative analysis of epidemiological and
clinical characteristics with mild and severe
inﬂuenza A (H1N1)
A.-R. Hu1 *, X.-Y. Liang1, W.Y. Xuan1, S.-W. Jiang1. 1Ningbo
Infectious Diseases Hospital, China
Objective: To comparatively analyze the epidemiological
and clinical characteristics of patients with severe
inﬂuenza A (H1N1).
Methods: The clinical data were analyzed retrospectively
from September 25, 2009 to November 23, 2009. Mild
patients were 33 cases and severe patients were 32 cases.
Results: Patients in the 2 groups were mainly young people.
The average age of mild group was 20.5±9.5 years old
vs 26.5±20.0 years old in severe group. Occupational
distribution of the 2 groups was mainly young staff and
students. Fever, cough, expectoration and fatigue were
prominent and characteristic features of the disease. The
ratio of hyperpyrexia (39ºC) and the duration of fever
were statistically signiﬁcant difference. There were no chest
tightness, shortness of breath and vomiting in mild group. All
patients in the 2 groups had throat congestion. No patients
in mild group had complication, 24 cases in severe group
had pneumonia and 8 cases had bronchial pneumonia. The
ratio of abnormal of WBC count and absolute neutrophil
count were statistically non-signiﬁcant difference, but the
abnormal of CK, LDH and liver function were statistically
signiﬁcant difference. All patients in severe group had
abnormal chest X-ray examinations vs normal in mild group.
All patients were successfully cured and discharged from
hospital by oseltamivir phosphate capsules, Chinese patent
medicine (Tanreqing injection) and symptomatic treatment.
There were statistically signiﬁcant difference of average
hospital stay in the 2 groups.
Conclusion: Patients with inﬂuenza A (H1N1) are mainly
young people. The complications of severe inﬂuenza A
(H1N1) are pneumonia, heart damage and liver function
abnormal and the process of the disease is in a extremely
dangerous state. Though the ratio is declining, early
detection, intensive care and active treatment should
be all the same taken. Traditional Chinese medicine has
comparative advantage and should be promoted.
PP-073 An analysis of the clinical features of A/H1N1
inﬂuenza infection
C.R. Zhang1 *, J.C. Lin1, M. Li1, H. Zhou1, W.L. Cui1. 1Huang
Pu Hospital of the First Afﬁliated Hospital, Sun Yat-sen
University, China
Objective: To reduce stuffs and patients being infected in
hospitals, the clinical features of A/H1N1 inﬂuenza infection
were studied.
Methods: The clinical data of 17 patients with A/H1N1
inﬂuenza were made a retrospectively investigation in June
2009, the data included the change of body temperature,
blood routine and chest X-rays check, 18 patients with
ordinary inﬂuenza were studied as the control group.
Results: There were not signiﬁcant difference for the
change of body temperature, blood routine (P> 0.05). The
chest X-rays check were normal in the two groups. All
patients were conﬁrmed positive for A/H1N1 RNA when they
had fever, and were negative for A/H1N1 RNA when they
had no fever in the A/H1N1 inﬂuenza group, those patients
with ordinary inﬂuenza were all negative for A/H1N1 RNA
when they had or not fever. These patients with A/H1N1
inﬂuenza or ordinary inﬂuenza had no complications, and
all had good prognosis.
Conclusion: A/H1N1 inﬂuenza did not have any special
clinical manifestations compared with ordinary inﬂuenza.
PP-074 Small interfering RNA (siRNA) mediated
inhibition of inﬂuenza A virus replication in
mammalian cell line
B. Kumar1 *, P. Kumar1, R. Rajput1, M. Khanna1.
1Department of Respiratory Virology, Vallabhbhai Patel
Chest Institute, University of Delhi, India
Background: Inﬂuenza A virus, since time immemorial, has
posed an acute worldwide threat to human health and
has been the cause of frequent epidemics and reoccurring
pandemics. Various RNA interference (RNAi) studies have
been carried out for the RNA-mediated RNA degradation in
a sequence-speciﬁc manner. NS1 gene of inﬂuenza viruses
plays a crucial role in inhibiting the interferon-mediated
responses in the host.
Methods: We have studied the viral replication inhibition
using siRNAs targeted against the conserved regions of the
NS1 gene of inﬂuenza A Virus. The NS1 gene was cloned in
pSecTag 2A vector and was co-transfected with 30, 40 and
50 pmoles of the designed siRNAs in MDCK cells. The same
concentrations of siRNAs were also transfected with the
whole virus (Inﬂuenza A/PR/8/34) to study the inhibition of
replication. RT-PCR and Real-time RT-PCR assays followed
by western blot analysis were performed to detect the
inhibition of the expression of NS1 gene.
Results: All the tests conﬁrmed an increase in inhibition
of the expression of NS1 gene with an increase in the
concentration of siRNA. The maximum inhibition (75%) of
the virus replication was observed at 50 pmoles of siRNA.
Conclusion: Our study demonstrates that siRNA is able to
cleave the target RNA at simulated physiological condition in
a sequence speciﬁc manner. An increase in down-regulation
of the cloned NS1 gene as well as a signiﬁcant protection
against inﬂuenza virus infection in MDCK cells was observed
with an increase in siRNA concentration from 30 50 pm.
The maximum inhibition of gene expression as well as viral
replication inhibition was observed at 50pm concentration
of siRNA.
PP-075 Expression of neuraminidase protein of H1N1
swine-origin inﬂuenza A virus (S-OIV) in insect
cells with a baculovirus expression system
H. Song1,2 *, Q. Wang1, Y. Li1, D. Zhang2, J. Cheng1.
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Objective: To construct the recombinant baculovirus
expressing 2009 pandemic H1N1 swine-origin inﬂuenza A
virus (S-OIV) Neuraminidase (NA) gene in insect cell.
Methods: The NA gene of Inﬂuenza A virus [A/California/
VRDL98/2009 (H1N1)] was cloned into pGEM-T easy
vector and then was ligated into baculovirus donor
plasmid pFastBacHTa after cutting by EcoRI and
Hind III. pFastBacHTa-NA was subsequently transformed
into DH10Bac E. coli competent cells, which contained the
baculovirus shuttle vector (Bacmid) and the helper plasmid
to generate a recombinant bacmid. The recombinant
baculovirus stock was prepared by transfecting the
recombinant bacmid DNA into the Sf9 insect cell for protein
expression after ampliﬁcation. Sodium dodecyl sulfate-
polyacrylamide gel electrophoresis (SDS-PAGE) and Western
blotting were performed to identify the antigenicity of the
recombinant protein.
